ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

KOSDAQ:034940 Revenue

ChoA Pharmaceutical Co., LTD. had revenue of 15.18B KRW in the quarter ending June 30, 2026, with 11.31% growth. This brings the company's total for the last twelve months to 61.16B, up 1.50% year-over-year. In the year 2025, ChoA Pharmaceutical Co., LTD. had annual revenue of 59.31B, down -5.40%. That makes ChoA Pharmaceutical Co., LTD. the 28,493rd largest company in the world by revenue and 1,749th in South Korea.

• Revenue (ttm): 61.16B
• Revenue Growth: +1.50%
• P/S Ratio: 0.19
• Revenue / Employee: 268.25M
• Employees: 228
• Market Cap: 11.44B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Korea 61.67B 100.0%
• Vietnam 26.26M 0.0%

Fiscal year ended Dec 31, 2025 See the full KOSDAQ:034940 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	59.31B	-3.38B	-5.40%
Dec 31, 2024	62.69B	-280.00M	-0.44%
Dec 31, 2023	62.97B	-5.91B	-8.57%
Dec 31, 2022	68.88B	11.32B	19.66%
Dec 31, 2021	57.56B	-7.80B	-11.93%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error